Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pegaldesleukin, a conjugate of polyethylene glycol and interleukin-2 (PEG-IL2), exhibits antiviral activity with potential applications in managing HIV. It may delay the progression of HIV infection by preserving the immune repertoire [1] [2] [3].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Pegaldesleukin, a conjugate of polyethylene glycol and interleukin-2 (PEG-IL2), exhibits antiviral activity with potential applications in managing HIV. It may delay the progression of HIV infection by preserving the immune repertoire [1] [2] [3]. |
Molecular Weight | N/A |
CAS No. | 141752-91-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pegaldesleukin 141752-91-2 inhibitor inhibit